Drug candidate SR9009 is a simple molecule that produces significant benefits (Image: The Scripps Research Institute)
The Scripps Research Institute has developed a drug that duplicates the benefits of exercise – at least for mice (image: Shutterstock)
A drug known as SR9009, which is currently under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice. Treated mice become lean, develop larger muscles and can run much longer distances simply by taking SR9009, which mimics the effects of aerobic exercise. If similar effects can be obtained in people, the reversal of obesity, metabolic syndrome, and perhaps Type-II diabetes might be the very welcome result.
Other Images from this Gallery